No abstract available
MeSH terms
-
Acute Disease
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Benzamides
-
Colitis / chemically induced*
-
Colitis / pathology
-
Colitis / therapy
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Dasatinib
-
Female
-
Gastrointestinal Hemorrhage / chemically induced*
-
Gastrointestinal Hemorrhage / pathology
-
Gastrointestinal Hemorrhage / therapy
-
Humans
-
Idarubicin / administration & dosage
-
Idarubicin / adverse effects
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Male
-
Middle Aged
-
Piperazines / administration & dosage
-
Piperazines / adverse effects
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects*
-
Rectal Diseases / chemically induced*
-
Rectal Diseases / pathology
-
Rectal Diseases / therapy
-
Thiazoles / administration & dosage
-
Thiazoles / adverse effects*
Substances
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Thiazoles
-
Cytarabine
-
Imatinib Mesylate
-
Dasatinib
-
Idarubicin